InvestorsHub Logo
Followers 11
Posts 344
Boards Moderated 0
Alias Born 02/01/2011

Re: Vanilla Fitbit post# 35347

Monday, 02/08/2021 8:24:40 AM

Monday, February 08, 2021 8:24:40 AM

Post# of 44690
hate to say it but I TOLD YOU SO
As long as GEM is making money from dragging this out, they will ... likely until AFTER February 15th...

because it pays for them:

https://www.ser-ag.com/en/resources/notifications-market-participants/significant-shareholders.html#/shareholder-details/TAL1S00025

Pursuant to a Share Subscription Facility agreement (SSF), GEM committed to provide up to CHF 50 million to RELIEF THERAPEUTICS Holding SA in exchange for registered shares of RELIEF THERAPEUTICS Holding SA in the period from January 20, 2021, to January 20, 2024, at the discretion of RELIEF THERAPEUTICS Holding SA, subject to certain exceptions and limitations. No drawdowns have been made until January 22, 2021, resulting in a remaining balance of the full amount under the SSF of CHF 50 million. GEM's purchase position has been calculated using the closing price of the registered shares of RELIEF THERAPEUTICS Holding SA on SIX Swiss Exchange on January 22, 2021 (CHF 0.41) and applying the 10% discount agreed in the SSF (resulting in a share price of CHF 0.369), by dividing the remaining balance under the SSF of CHF 50 million by such share price of CHF 0.369. However, according to the terms of the SSF, future subscription prices under the SSF will correspond to 90% of the average of the closing bid prices on SIX Swiss Exchange during the relevant reference period, which corresponds to 15 trading days following RELIEF THERAPEUTICS Holding SA's relevant subscription request, subject to certain exceptions and limitations. Therefore, note that the actual subscription price at which GEM may be requested to subscribe for registered shares of RELIEF THERAPEUTICS Holding SA under the SSF may be lower or higher than the share price applied above, and accordingly, the number of voting rights GEM may acquire as a result thereof may be higher or lower than as set forth in this disclosure.[color=red][/color]